Abstract
The design and effectiveness of strategies to promote long-term graft acceptance requires a fundamental understanding of the mechanisms underlying acute and chronic rejection. This chapter discusses the two pathways of allorecognition-direct and indirect-and suggests that the direct pathway plays a major role in the early weeks after transplantation and that the indirect pathway may contribute to the process of chronic rejection. The results of in vitro and in vivo experimental models are discussed, together with clinical data.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Bach F., Bach M., and Sondel P. (1976) Differential function of major histocompatibility complex antigens in T lymphocyte activation. Nature 259, 273–281.
Skinner M. and Marbrook J. (1976) An estimation of the frequency of frequency of precursor cells which generate cytotoxic lymphocytes. J. Exp. Med. 143, 1562–1567.
Fischer-Lindahl K. and Wilson D. (1976) J. Exp. Med. 145, 500–507.
Hunig T. and Bevan M. (1980) Self-H2 antigens influence the specificity of alloreactive cells. J. Exp. Med. 151, 1288–1298.
Lombardi G., Sidhu S., Batchelor J., and Lechler R. (1989) Allorecognition of DR1 by T cells from a DR/Dw13 responder mimics self-restricted recognition of endogenous peptides. Proc. Natl. Acad. Sci. 86, 4190–4194.
Lombardi G., Sidhu S., Daly M., Batchelor J., Makgoba W., and Lechler R. (1990) Are primary alloresponses truly primary? Int. Immunol. 2, 9–13.
Matzinger P. and Bevan M. (1977) Why do so many lymphocytes respond to major histocompatibility antigens? Cell. Immunol. 29, 1–5.
Bevan M. (1984) High determinant density may explain the phenomenon of alloreactivity. Immunol. Today 5, 128–130.
Harding C. and Unanue E. (1990) Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T cell stimulation. Nature 346, 574.
Lechler R., Lombardi G., Batchelor J., Reinsmoen N., and Bach F. (1990) The molecular basis of alloreactivity. Immunol. Today 11, 83–88.
Merkenschlager M., Graf D., Lovatt M., Bommhardt U., Zamoyska R., and Fisher A. (1997) How many thymocytes audition for selection? J. Exp. Med. 186,1149–1158.
Pietra B., Wiseman A., Bolwerk A., Rizeq M., and Gill R. (2000) CD4 T cellmediated cardiac allograft rejection requires donor but not host MHC class II. J. Clin. Invest. 106, 1003–1010.
Braun M., McCormack A., Webb G., and Batchelor J. (1993) Mediation of acute but not chronic rejection of the MHC incompatible rat kidney grafts by alloreactive CD4 T cells activated by the direct pathway of sensitisation. Transplantation 55, 177–182.
Austyn J. and Larsen C. (1990) Migration patterns of dendritic leucocytes. Implications for transplantation. Transplantation 49, 1–7.
Harding F. and Allison J. (1993) CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 176, 519–529.
Dai R., Grammar S., and Streilein J. (1993) Fresh and cultured Langerhans cells display differential capacities to activate hapten-specific T cells. J. Immunol. 150, 59–66.
Streilein J., Grammar S., Yoshikawa T., Demidem A., and Vermeer M. (1990) Functional dichotomy between Langerhans cells that present antigen to naive and to memory/effector T lymphocytes. Immunol. Rev. 117, 159–183.
Milton A., Spencer S., and Fabre J. (1986) The effects of cyclosporin A on the induction of donor class I and class II MHC antigens in heart and kidney allografts in the rat. Transplantation 42, 337.
Hosenpud J., Shipley J., and Wagner C. (1992) Cardiac allograft vasculopathy, Current concepts, recent developments and future directions. J. Heart Lung Transplant. 11, 9–23.
Deacock S. J. and Lechler R. L. (1992) Positive correlation of T cell sensitization with frequencies of alloreactive T helper cells in chronic renal failure patients. Transplantation 54, 338–343.
Mason P., Robinson C., and Lechler R. (1996) Detection of donor-specific hyporesponsiveness following late failure of human renal allografts. Kidney Int. 50, 1019–1025.
Cramer D., Chapman F., Wu G., Harnaha J., Quian S., and Makowka L. (1990) Cardiac transplantation in the rat. II. Alteration of the severity of donor graft arteriosclerosis by modulation of the host immune response. Transplantation 50, 554–558.
Shin Y., Adams D., Wyner L., Akalin E., Sayegh M., and Karnovsky M. (1995) Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model. Transplantation 59, 1647–1653.
Cramer D., Qian S., Harnaha J., et al. (1989) Cardiac transplantation in the rat, I. The effect of histocompatibility differences on graft atherosclerosis. Transplantation 47, 414–419.
Isoniemi H., Nurminen M., Tikkanen M., et al. (1994) Risk factors predicting chronic rejection of renal allografts. Transplantation 57, 68–72.
Lechler R. and Batchelor J. (1982) Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med. 155, 31–41.
Benichou G., Takizawa A., Olson A., McMillan M., and Sercarz E. (1992) Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J. Exp. Med. 175, 305–308.
Fangmann J., Dalchau R., and Fabre J. (1992) Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J. Exp. Med. 175, 1521–1529.
Benham A., Sawyer G., and Fabre J. (1995) Indirect T cell recognition of donor antigens contributes to the rejection of vascularized kidney allografts. Transplantation 59, 1028–1032.
Grusby M., Johnson R., Papaioannou V., and Glimcher L. (1991) Depletion of CD4 T cells in major histocompatibility complex class II-deficient mice. Science 253, 1417–1420.
Auchinloss H. J., Lee R., Shea S., Markowitz J., Grusby M., and Glimcher L. (1993) The role of ‘indirect’ recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc. Natl. Acad. Sci. USA 90, 3373–3377.
Sayegh M., Perico N., Gallon L., Imberti O., Hancock W., Remuzzi G., et al. (1994) Mechanisms of acquired thymic unresponsiveness to renal allografts. Transplantation 58, 125–132.
Chicz R., Urban R., Lane W., Gorga S., Stern L., Vignali D., et al. (1992) Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC relayed molecules and are heterogeneous in size. Nature 358, 764–768.
Essaket S. and Fabron J. (1990) Co-recognition of HLA-A1 and HLA DPw3 by a human CD4+ alloreactive T cell clone. J. Exp. Med. 172, 387–390.
de Koster H., Anderson D., Termijtelen A. (1990) T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLADR3 molecoles by HLA-DP. J. Exp. Med. 169, 1191–1196.
Hart D. and Fabre J. (1979) Quantitative studies on the tissue distribution of Ia and SD antigens in the DA and Lewis rat strains. Transplantation 27, 110.
Milton A., Spencer S., and Fabre J. (1986) Massive induction of donor type class I and class II MHC antigens in rejecting cardiac allografts in the rat. J. Exp. Med. 161, 98.
Auchinloss H. J. and Sutan H. (1996) Antigen processing and presentation in transplantation. Curr. Opin. Immunol. 8, 681–687.
Joos J., Zanker B., Wagnar H., and Kabelitz D. (1988) Quantitative assessment of interleukin-2-producing alloreactive human T cells by limiting dilution analysis. J. Immunol. Methods 112, 85.
Liu Z., Sun Y., Xi Y., Maffai A., Reed E., Harri,s P., et al. (1993) Contribution of direct and indirect allorecognition pathways to T cell alloreactivity. J. Exp. Med. 177, 1643–1650.
Van Besouw N., Vaessen L., Daane C., Jutte N., Balk A., Claas F., et al. (1996) Peripheral monitoring of direct and indirect alloantigen presentation pathways in clinical heart transplant recipients. Transplantation 61, 165–167.
Liu Z., Coloval A., Tugulea S., Reed E., Fisher P., Mancini D., et al. (1996) Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J. Clin. Invest. 98, 1150–1157.
Frasca L., Amendola A., Hornick P., Uren J., Marelliberg F., Lechler R., et al. (1998) The role of donor and recipient antigen presenting cells in priming and maintaining T cells with indirect specificity. Transplantation 66, 1238–1243.
Taylor D., Ibrahim H., Tolman D., and Hess M. (1991) Accelerated coronary arteriosclerosis in cardiac transplantation. Transplant. Rev. 5, 165–174.
Russell P., Chase C., Winn H., and Colvin R. (1994) Coronary atherosclerosis in transplanted rat heart. II. The importance of humoral immunity. J. Immunol. 152, 389–398.
Dunn M. J., Crisp S. J., Rose M. L., Taylor P. M., Yacoub M. H. (1992) Antiendothelial antibodies and coronary artery disease after cardiac transplantation. Lancet. 339, 1566–1570.
Reed E. F., Hong B., Ho E., Harris P. E., Weinberger J., Suciu-Foca N. (1996) Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. Transplantation. 61, 566–572.
Bradley J., Mowat A. M., and Bolton E. (1992) Processed MHC class I alloantigen as the stimulus for CD4+ T-cell dependent antibody-mediated graft rejection. Immunol. Today 13(11), 434–438.
Simitsek P., Campbell D., Lanzavecchia A., Fairweather N., and Watts C. (1995) Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J. Exp. Med. 181, 1957.
Sallusto F. and Lanzavecchia A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down regulated by tumour necrosis factor alpha. J. Exp. Med. 179, 1109.
Benzaquen L., Nicholson-Weller A., and Halperin J. (1994) Terminal complement proteins C5b-9 release fibroblast growth factor and platelet derived growth factor from endothelial cells. J. Exp. Med. 179, 985–992.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Hornick, P. (2006). Direct and Indirect Allorecognition. In: Hornick, P., Rose, M. (eds) Transplantation Immunology. Methods In Molecular Biology™, vol 333. Humana Press. https://doi.org/10.1385/1-59745-049-9:145
Download citation
DOI: https://doi.org/10.1385/1-59745-049-9:145
Publisher Name: Humana Press
Print ISBN: 978-1-58829-544-6
Online ISBN: 978-1-59745-049-2
eBook Packages: Springer Protocols